At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
We came to Biogen to solve the unsolvable. We stay to create new possibilities and grow together. We work fearlessly and go beyond because we care deeply about making a difference and changing lives. All legitimate correspondence from a Biogen employee will come from “@biogen.com” or “@smartrecruiters.com” email accounts.
Each year, Biogen commits significant financial support through a variety of corporate giving initiatives that positively impact the communities where we live and work.
Grants & Sponsorships
Biogen’s global grant and giving strategy aims to catalyze scientific innovation, address unmet patient needs, and advance medical and disease education through funding a variety of programs and initiatives.
General grant: Financial contribution to support a program or project that does not fit any of the other defined grant categories
Fellowships: Funding for training programs created by medical schools, academic medical centers, teaching hospitals, or other healthcare-related organizations to support faculty and visiting scholars to advance their educational and research activities.
Sponsorships: Financial contribution provided to eligible organizations or institutions to support specific purposes or events in exchange for some tangible benefit for Biogen.
The Biogen Foundation supports access to science education for diverse populations and to essential human services for children and families in the communities in which we work and live. Learn more about our commitment to sparking a passion for science and discovery.
Biogen supports medical research that advances scientific knowledge of disorders relevant to our therapeutic portfolio and products aimed toward improving the quality of patient care.
The following study types are considered for medical research support:
Investigatory-Initiated Trial (IIT): An unsolicited preclinical, clinical, outcomes- or disease-state-related study for which a proposal is independently generated by an investigator.
Sponsor Research Agreement (SRA): A collaboration between Biogen and an investigator on a research proposal. Biogen and the investigator collaborate on the design and the interpretation of the results.
You are now leaving Biogen’s corporate website.
Third Party Sites
Biogen assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of Biogen or this website.